Global Health Clinics Ltd. (CSE: MJRX)
Canada
· Delayed Price · Currency is CAD 0.0100
-0.0300 (-75.00%)
Dec 20, 2024, 4:00 PM EST
Global Health Clinics Income Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 30, 2024 | Jul '24 Jul 30, 2024 | Jul '23 Jul 30, 2023 | Jul '22 Jul 30, 2022 | Jul '21 Jul 30, 2021 | Jul '20 Jul 30, 2020 | 2019 - 2015 |
| Revenue | 0.08 | 0.08 | 0.1 | 0.15 | 0.23 | 0.35 | Upgrade
|
| Revenue Growth (YoY) | -19.34% | -19.34% | -29.94% | -34.78% | -36.08% | -27.82% | Upgrade
|
| Cost of Revenue | 0.02 | 0.02 | 0.02 | 0.03 | 0.05 | 0.16 | Upgrade
|
| Gross Profit | 0.06 | 0.06 | 0.08 | 0.12 | 0.18 | 0.19 | Upgrade
|
| Selling, General & Admin | 1 | 1 | 1.63 | 1.52 | 1.31 | 1.52 | Upgrade
|
| Research & Development | - | - | - | 0.01 | 0.04 | - | Upgrade
|
| Operating Expenses | 1 | 1 | 1.63 | 1.53 | 6.01 | 1.59 | Upgrade
|
| Operating Income | -0.94 | -0.94 | -1.55 | -1.42 | -5.83 | -1.4 | Upgrade
|
| Interest Expense | -0.13 | -0.13 | -0.05 | -0.01 | -0 | - | Upgrade
|
| Interest & Investment Income | 0 | 0 | - | - | 0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -0.02 | -0.02 | 0.06 | -0.05 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | -1.08 | -1.08 | -1.63 | -1.37 | -5.88 | -1.44 | Upgrade
|
| Asset Writedown | - | - | - | - | -2.51 | - | Upgrade
|
| Legal Settlements | - | - | - | - | -0.09 | - | Upgrade
|
| Other Unusual Items | 0 | 0 | 0 | -0 | - | -0.27 | Upgrade
|
| Pretax Income | -1.08 | -1.08 | -1.63 | -1.37 | -8.48 | -1.7 | Upgrade
|
| Net Income | -1.08 | -1.08 | -1.63 | -1.37 | -8.48 | -1.7 | Upgrade
|
| Net Income to Common | -1.08 | -1.08 | -1.63 | -1.37 | -8.48 | -1.7 | Upgrade
|
| Shares Outstanding (Basic) | 9 | 9 | 9 | 4 | 2 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 9 | 9 | 4 | 2 | 0 | Upgrade
|
| Shares Change (YoY) | - | - | 150.82% | 77.50% | 575.42% | 29.56% | Upgrade
|
| EPS (Basic) | -0.11 | -0.11 | -0.17 | -0.37 | -4.02 | -5.46 | Upgrade
|
| EPS (Diluted) | -0.11 | -0.11 | -0.17 | -0.37 | -4.02 | -5.46 | Upgrade
|
| Free Cash Flow | -0.5 | -0.5 | -1.01 | -1.49 | -0.83 | -0.96 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.05 | -0.11 | -0.40 | -0.39 | -3.07 | Upgrade
|
| Gross Margin | 76.99% | 76.99% | 78.40% | 79.01% | 78.97% | 53.19% | Upgrade
|
| Operating Margin | -1127.39% | -1127.39% | -1508.56% | -963.98% | -2591.48% | -398.39% | Upgrade
|
| Profit Margin | -1299.62% | -1299.62% | -1580.10% | -932.61% | -3766.83% | -483.99% | Upgrade
|
| Free Cash Flow Margin | -598.52% | -598.52% | -981.81% | -1014.11% | -366.87% | -272.13% | Upgrade
|
| EBITDA | -0.93 | -0.93 | -1.55 | -1.41 | -5.83 | -1.35 | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0.06 | Upgrade
|
| EBIT | -0.94 | -0.94 | -1.55 | -1.42 | -5.83 | -1.4 | Upgrade
|
| Advertising Expenses | - | - | 0.59 | 0.44 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.